维普中文期刊产品整合服务
96篇 您的检索式:作者名="Herrlinger U"
    题名 作者 年代 出处 被引量
1Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03 显示文摘Herrlinger U Rieger J Koch D 2006J Clin Oncol2006,24,27:1
2NOA-03 trial of high- dose methotrexate in primary central nervous system lym- phoma: final report 显示文摘Herrlinger U Kuker W Uhl M 2005Ann Neurol2005,57,:1
3NOA-03 trial of high- dose methotrexate in primary central nervous system lym- phoma: final report 显示文摘Herrlinger U Kuker W Uhl M 2005Ann Neurol2005,57,:1
4New aspects of im- munotherapy of leptomeningeal metastases from breast can- cer to hormonal therapy显示文摘Herrlinger U Weller M Schabet M 2001Neurol2001,56,3:1
5Seizures in patients with low-grade gliomas-incidence, pathogenesis, surgical anagement,and pharmacotherapy显示文摘Kurzwelly D Herrlinger U Simon M 2010Adv Tech Stand Neu- rosurg2010,35,:1
6Primary central nervous system lymphoma:from clinical presentation to diagnosis显示文摘HERRLINGER U SCHABET M BITZER M 1999J Neurooncol1999,43,3:1
7MRI features of primary central nervous system lymphomas at presentation 显示文摘Uhring U Herrlinger U Krings T 2001Neurol2001,57,3:1
8Neural precursor cells for delivery of replication-conditional HSV-1vector to intracerebral gliomas显示文摘 Woiciechowski C Sena EM 2000Mol Ther2000,1,4:1
9German Cancer Society Neuro-oneology Working Group NOA-03 mul- ticenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma显示文摘Herrlinger U Schabet M Brugger W 2002Ann Neurol2002,51,2:1
10German Cancer Society Neruo Oncology Working Group NOA-03 multicenter trial of single agent higll-dose methotrexate for primary central nervous system lymphoma显示文摘 Schabet M Brugger W 2002Ann Neural2002,51,:1
11MRI features of primary central nervous system lymphomas at presentation显示文摘Buhring U Herrlinger U Krings T 2001Neurology2001,57,3:1
12MRI features of primary central nervous system lymphomas at presentation显示文摘Btihring U Herrlinger U Krings T 2001Neurology2001,57,3:1
13German Cancer Society Neuro - Oncology Working Group NOA - 03 multicenter trial of single - agent high - dose methotrexate for primary central nervous system lymphoma显示文摘Herrlinger U Schabet M Brugger W 2002Ann Neurol2002,51,5:1
14MRI features of primary central nervous system lymphomas at presentation 显示文摘Buhring U Herrlinger U Krings T 2001Neurology2001,57,3:1
15Clinical presentation and therapeutic outcome in 26 patients with primary CNS lymphoma 显示文摘Herrlinger U Schabel M Clemens M 1998Acta Neurol Scand1998,97,4:1
16Gliomatosis cerebri: molecular pathology and clinical course显示文摘Herrlinger U Felsberg J Kuker W 2002Ann Neurol2002,52,4:1
17Primary central nervous system lymphoma 1991-1997:outcome and late adverse effects after combined modality treatment显示文摘Herrlinger U Schabet M Brugger W 2001Cancer2001,91,1:1
18MRI features of primary central nervous system lymphomas at presentation显示文摘Biihring U Herrlinger U Krings T 2001Neurology2001,57,3:1
19MRI features of pfimary central nervous system lymphomas at presentation显示文摘Uhring U Herrlinger U Krings T 2001Neurol2001,57,3:1
20German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma显示文摘Herrlinger U Schabet M Brugger W 2002Ann Neurol2002,51,2:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费